Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• ACCEL Lite: CAC Use in CV Risk Stratification: CorCal Outcomes
  In this episode, Allen J. Taylor, MD, FACC and Joseph Brent Muhlestein, MD, FACC discuss “CorCal: Pooled Cohort Equations versus Coronary Artery Calcium Score in ASCVD Primary Prevention”.
• Arrhythmia-Related Trials Featured at ESC Congress 2026: Implications on Clinical Practice
  ESC Congress 2026 featured several arrhythmia-related clinical trials. SINGLE-AF investigated anticoagulation in patients with atrial fibrillation (AFib) and intermediate stroke risk, PVI-SHAM-AF compared whether catheter ablation improves AFib-related quality of life more than a sham procedure, ASPIRED tested 14-day ECG monitoring in patients with unexplained syncope...
• AMUNDSEN: Does Early Evolocumab Improve Outcomes in Acute MI?
  Lipid lowering after acute myocardial infarction (MI) is central to secondary prevention, but stepwise therapy may delay LDL-C target attainment. The AMUNDSEN trial, presented at ESC Congress 2026 and simultaneously published in JAMA, assessed whether pre-PCI evolocumab could accelerate LDL-C reduction and improve clinical outcomes.
• ACC CardiaCast: What Clinicians May Be Missing: Overcoming Barriers to Aortic Stenosis Diagnosis
  This episode is part of ACC’s ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis. Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis.
• JACC: Advances Report Highlights Continued Sex Disparities in CV Clinical Trials
  Despite longstanding inclusion policies to increase the enrollment of women in cardiovascular clinical trials, a brief report published Sept. 25 in JACC: Advances confirms that this disparity persists, with women representing only a third of patients in the late-breaking clinical trials (LBCTs) presented at ACC.26.